QCM
AQST icon

Quantinno Capital Management’s Aquestive Therapeutics AQST Stock Holding History

Quantinno Capital Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
34,597
+16,583
+92% +$69.8K ﹤0.01% 3365
2026
Q1 		$74.8K Buy
18,014
+6,221
+53% +$25.2K ﹤0.01% 3271
2025
Q4 		$76.2K Sell
11,793
-6,242
-35% -$38.9K ﹤0.01% 3134
2025
Q3 		$101K Buy
+18,035
New +$78K ﹤0.01% 2881

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Quantinno Capital Management's AQST Position: Q2 2026 in Review

Quantinno Capital Management increased its Aquestive Therapeutics (AQST) stake by 92% in Q2 2026, buying an estimated $69.8K and bringing the position to 34,597 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

Quantinno Capital Management first reported a position in AQST in Q3 2025 and has held it in 4 quarters since. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Quantinno Capital Management held 34,597 shares of Aquestive Therapeutics worth $144K as of Q2 2026.
  • Quantinno Capital Management bought 16,583 Aquestive Therapeutics shares in Q2 2026, an estimated $69.8K.
  • Aquestive Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3365 holding.
  • Quantinno Capital Management first reported a position in Aquestive Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.